Nuon Therapeutics Inc. Announces Gout Program Study Results to Be Presented at the American College of Rheumatology
9/29/2010 10:13:29 AM
More...
|
Nuon Therapeutics Inc. Announces Results of Studies Confirming the Uric Acid Lowering Activity of Tranilast
6/22/2010 6:27:50 AM
More...
|
Nuon Therapeutics Inc. Announces Positive Topline Results from a Phase 2a Study in Hyperuricemia
6/16/2010 6:25:39 AM
More...
|
Nuon Therapeutics Inc. Announces Data Demonstrating Uric Acid Lowering Activity of Tranilast to Be Presented at EULAR 2010
6/3/2010 11:58:31 AM
More...
|
Nuon Therapeutics Inc. Announces Data Demonstrating Uric Acid Lowering Activity of Tranilast to Be Presented at EULAR 2010
6/3/2010 9:25:20 AM
More...
|
Nuon Therapeutics Inc. Names Lee Rauch Chief Executive Officer
5/13/2010 6:11:07 AM
More...
|
Nuon Therapeutics Inc. to Present Update on Programs in Rheumatoid Arthritis and Gout at 2010 Biotechnology Industry Organization (BIO) International Convention
4/29/2010 9:41:40 AM
More...
|
Nuon Therapeutics Inc. Identifies Novel Use and Advances NU1618 into Development for Chronic Hyperuricemia in Patients with Gout
4/21/2010 10:06:09 AM
More...
|
Affymax, Inc. (AFFY) CEO Arlene Morris Joins Nuon Therapeutics Inc.'s Board of Directors as Chair
7/16/2009 9:26:09 AM
More...
|
Nuon Therapeutics Inc. Appoints Paulette Dillon, Chief Business Officer, and Tito Serafini, Chief Scientific Officer
7/16/2009 9:20:18 AM
More...
|
|